RT
Raymond Joseph Tesi
President and CEODirector10% Owner

Raymond Joseph Tesi insider trades: Inmune Bio (INMB) stock buys and sales

President and CEO, Inmune Bio Last trade Sep 12, 2024 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2019
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Raymond reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 12, 2024INMB↑ Buy$98K
May 26, 2022INMB↑ Buy$40K
Nov 3, 2021INMB↓ Sell$73K
Oct 27, 2021INMB↓ Sell$130K
Oct 22, 2021INMB↓ Sell$472K
Jul 8, 2021INMB↓ Sell$602K
Aug 20, 2019INMB↑ Buy$12K
Aug 9, 2019INMB↑ Buy$14K
Jun 3, 2019INMB↑ Buy$60K
May 2, 2019INMB↑ Buy$110K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Raymond Joseph Tesi's insider trades

Raymond Joseph Tesi is President and CEO at Inmune Bio (INMB). Since May 2, 2019, Raymond has reported 6 open-market purchases worth $334K and 4 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INMB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.